UiPath, Inc. (NYSE:PATH – Get Free Report) CEO Daniel Dines sold 1,250,000 shares of the firm’s stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $13.44, for a total value of $16,800,000.00. Following the transaction, the chief executive officer owned 30,241,238 shares of the company’s stock, valued at $406,442,238.72. The trade was a 3.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Daniel Dines also recently made the following trade(s):
- On Wednesday, August 19th, Daniel Dines sold 1,402,347 shares of UiPath stock. The stock was sold at an average price of $16.07, for a total transaction of $22,535,716.29.
UiPath Price Performance
Shares of UiPath stock opened at $13.70 on Thursday. The stock has a market cap of $7.14 billion, a price-to-earnings ratio of 20.44, a PEG ratio of 1.26 and a beta of 1.01. The firm’s 50-day moving average is $14.57 and its 200 day moving average is $12.44. UiPath, Inc. has a 1 year low of $9.20 and a 1 year high of $19.84.
UiPath (NYSE:PATH – Get Free Report) last released its quarterly earnings data on Thursday, September 3rd. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. The business had revenue of $410.26 million during the quarter, compared to analyst estimates of $397.77 million. UiPath had a net margin of 21.03% and a return on equity of 9.70%. UiPath’s revenue was up 13.3% compared to the same quarter last year. During the same period last year, the business earned $0.15 EPS. On average, equities analysts expect that UiPath, Inc. will post 0.49 EPS for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. BMO Capital Markets decreased their price objective on shares of UiPath from $18.00 to $15.00 and set a “market perform” rating for the company in a report on Thursday, September 24th. Wells Fargo & Company increased their target price on UiPath from $13.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday, September 4th. Oppenheimer reissued a “market perform” rating on shares of UiPath in a report on Friday, September 4th. Citigroup assumed coverage on UiPath in a research note on Tuesday, September 8th. They issued a “buy” rating and a $23.00 price target for the company. Finally, Barclays upped their price target on UiPath from $14.00 to $17.00 and gave the company an “equal weight” rating in a report on Friday, September 4th. Four research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $15.69.
View Our Latest Analysis on UiPath
Institutional Investors Weigh In On UiPath
Large investors have recently added to or reduced their stakes in the stock. Trifecta Capital Advisors LLC bought a new position in shares of UiPath during the 2nd quarter valued at $27,000. CoreCap Advisors LLC boosted its stake in shares of UiPath by 68.7% in the 3rd quarter. CoreCap Advisors LLC now owns 2,679 shares of the company’s stock worth $34,000 after buying an additional 1,091 shares during the last quarter. AdvisorNet Financial Inc grew its holdings in shares of UiPath by 750.0% in the first quarter. AdvisorNet Financial Inc now owns 3,400 shares of the company’s stock worth $38,000 after acquiring an additional 3,000 shares during the period. Global Retirement Partners LLC bought a new stake in shares of UiPath in the second quarter worth $57,000. Finally, Versant Capital Management Inc grew its holdings in shares of UiPath by 103.6% in the third quarter. Versant Capital Management Inc now owns 4,845 shares of the company’s stock worth $62,000 after acquiring an additional 2,465 shares during the period. Institutional investors own 62.50% of the company’s stock.
UiPath Company Profile
UiPath, Inc develops enterprise automation software that helps organizations automate repetitive, rules-based and increasingly complex business processes. Its platform combines robotic process automation with artificial intelligence, workflow orchestration, process mining, document processing and application integration capabilities.
The company’s products are designed to support the discovery, development, deployment and management of software robots and AI-powered automations across functions such as finance, customer service, human resources, information technology and operations.
See Also
- Five stocks we like better than UiPath
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
